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Sodium salicylate during the first 7 days of lactation affects the entire lactation
Abstract
Inflammation has been proposed as a contributor to metabolic disorders in transition dairy cows. The
purpose of this experiment was to determine if a non-steroidal anti-inflammatory drug, sodium salicylate
(SS), benefits transition cows. At calving, 78 cows [primiparous (1P) n = 39; 2nd lactation (2P) n = 24; ≥3
lactations (3P) n = 15] were assigned alternately to either a control or SS treatment for 7 days and
production responses were evaluated through the entire lactation. Treatment was administered via
individual water bowls, delivering a mean of 123 ± 5.5 (mean ± standard deviation) grams salicylate per
day during the 7 days of treatment. Cows were followed throughout the lactation by monthly milk yield
and component testing, and the effects of treatment on the risk of leaving the herd and on normalized
305-day milk, fat, and protein yields were determined by Fisher's exact test and mixed model analysis,
respectively. Treatment influenced both 305-day milk and fat yields differently across parities. Milk yield
was increased by 17% in 3P SS cows (4,374 ± 1,549 lb greater for 3P SS cows). Primiparous SS cows
tended to produce 2,155 ± 824 lb less 305-day milk than control cows; no differences were detected for
2P cows. Furthermore, 3P SS cows produced 285 ± 50 lb more 305-day milk fat and tended to produce
108 ± 40 lb more 305-day milk protein. No effects were detected in 1P or 2P cows. A treatment by parity
interaction was observed for the risk of leaving the herd where 1P cows treated with SS tended to have a
greater risk of leaving the herd than controls (30% vs. 6% risk). Treatment did not alter herd retention in 2P
or 3P groups, and SS had no effect on the risk of leaving the herd overall. Results indicate that SS has
long-term effects on lactation characteristics of aged cows, particularly on fat metabolism, but has
potential negative effects for primiparous cows.; Dairy Day, 2012, Kansas State University, Manhattan, KS,
2012; Dairy Research, 2012 is known as Dairy Day, 2012
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Sodium Salicylate during the First 7 Days of Lactation
Affects the Entire Lactation
J. K. Farney, L. K. Mamedova, J. E. Minton, J. F. Coetzee, L.C. Hollis, and
B. J. Bradford

Summary
Inflammation has been proposed as a contributor to metabolic disorders in transition dairy
cows. The purpose of this experiment was to determine if a non-steroidal anti-inflammatory
drug, sodium salicylate (SS), benefits transition cows. At calving, 78 cows [primiparous (1P) n
= 39; 2nd lactation (2P) n = 24; ≥3 lactations (3P) n = 15] were assigned alternately to either a
control or SS treatment for 7 days and production responses were evaluated through the entire
lactation. Treatment was administered via individual water bowls, delivering a mean of 123 ±
5.5 (mean ± standard deviation) grams salicylate per day during the 7 days of treatment. Cows
were followed throughout the lactation by monthly milk yield and component testing, and the
effects of treatment on the risk of leaving the herd and on normalized 305-day milk, fat, and
protein yields were determined by Fisher’s exact test and mixed model analysis, respectively.
Treatment influenced both 305-day milk and fat yields differently across parities. Milk yield
was increased by 17% in 3P SS cows (4,374 ± 1,549 lb greater for 3P SS cows). Primiparous
SS cows tended to produce 2,155 ± 824 lb less 305-day milk than control cows; no differences
were detected for 2P cows. Furthermore, 3P SS cows produced 285 ± 50 lb more 305-day milk
fat and tended to produce 108 ± 40 lb more 305-day milk protein. No effects were detected in
1P or 2P cows. A treatment by parity interaction was observed for the risk of leaving the herd
where 1P cows treated with SS tended to have a greater risk of leaving the herd than controls
(30% vs. 6% risk). Treatment did not alter herd retention in 2P or 3P groups, and SS had no
effect on the risk of leaving the herd overall. Results indicate that SS has long-term effects on
lactation characteristics of aged cows, particularly on fat metabolism, but has potential negative
effects for primiparous cows.
Key words: lactation, postpartum health, sodium salicylate

Introduction
The transition period is a time of metabolic problems for dairy cattle, which causes substantial
costs for producers. A majority of the metabolic issues stem from the negative energy balance associated with the increase in nutrients needed for the mammary gland. It has been hypothesized
that inflammation also plays a role in the development of metabolic disorders such as fatty liver
and ketosis. Non-steroidal anti-inflammatory drugs (NSAID) are used to combat the effects
of inflammation (i.e., pain, redness, and swelling). These types of drugs have been used in dairy
research as a component of treatment protocols for bacterial infections (primarily mastitis);
however, a few NSAIDs have been used in metabolic disorders.
We recently conducted a study to evaluate responses to oral delivery of the NSAID sodium
salicylate (SS; the parent compound for aspirin) during the first week of lactation. Intensive
measurements were conducted during the first 21 days of lactation for this trial, during which
we observed an increase in milk yield and incidence of metritis in older cows as well as an
increase in energy-corrected milk and milk fat yield by week 3 across all cows treated with SS.
5
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The purpose of this investigation was to determine if oral SS treatment during the first 7 days in
milk (DIM) has sustained impacts through the entire lactation.

Experimental Procedures
Seventy-eight Holstein cows [primiparous (1P), n=39; 2nd lactation (2P), n=24; ≥3rd lactation
cows (3P,) n=15] from the Kansas State University Dairy Teaching and Research Center were
used in the trial. Cows were assigned to two treatments on the day of parturition. Cows that
had lameness issues or milk fever before the initiation of treatment were excluded. Treatments
were balanced for parity and consisted of 7-day control or SS treatments administered through
individual water bowls. Cows were housed in tie-stall facilities, fed ad-libitum at 6:00 a.m. and
6:00 p.m., and milked thrice daily (2:00 a.m., 10:00 a.m., and 6:00 p.m.). On the eighth day
after calving, all cows were provided regular water for the remainder of lactation. Herd management data and DHIA production records were used for a retrospective analysis of wholelactation production and risk of leaving the herd. Cows that did not remain in the herd for a
subsequent calving were considered to have left the herd, and the reason entered was recorded.
Predicted 305-day yields of milk, fat, and protein generated by DHIA were used for all cows for
which a value was generated. Predictions were not available for 3 cows that left the herd prior
to 95 DIM. To test for randomization bias in milk production, treatment effects on predicted
transmitting ability (PTA) for milk, fat, and protein yield were tested, and no significant differences between treatments were observed (all P < 0.50). An additional potential confounding
factor was the enrollment of 27 of the cows (14 control and 13 SS cows) in a nutrition study
following the completion of the salicylate study. The study was a Latin square design with treatments that failed to influence any measured outcome. Therefore, the simple effect of enrollment
in the study was included in the model. Statistical analysis of 305-day milk, fat, and protein
yields were carried out using JMP (version 8.0) to estimate the fixed effects of treatment, parity,
treatment by parity interaction, and subsequent study enrollment. The PTA for the variable of
interest was included as a covariate to account for genetic contributions to variance.

Results and Discussion
No overall treatment effect (P = 0.16) was observed for the 305-day milk yield, but an interaction of treatment and parity (P < 0.01, Table 1) was detected. Salicylate administration
increased (P = 0.05) 305-day milk yield in 3P cows by 4,384 ± 1,552 lb but decreased it in 1P
cows by 2,155 ± 824 lb (Figure 1). Estimated 305-day milk fat yield was increased by 13% in SS
cows (P < 0.001; Table 1). A treatment by parity interaction was observed, where 3P SS cows
produced 318 ± 55 lb more fat during the entire lactation than 3P controls (34% increase,
P < 0.001; Figure 2). The 305-day protein yield was not affected by treatment (P > 0.50), but
a treatment by parity interaction was detected in which 3P SS cows tended (P = 0.06) to have
greater protein yield than 3P CON (14% increase; Figure 3).
A treatment by parity interaction was observed (P < 0.05) for risk of leaving the herd; 1P SS
cows tended (P < 0.10) to have a greater risk of leaving the herd than 1P controls (6% risk vs.
30% risk, Table 2). No differences were observed between treatments in 2P and 3P groups. The
specific causes of removal from the herd also were statistically evaluated, but treatment did not
impact any of these conditions. The most common reasons that cows left the herd were reproductive issues and chronic mastitis (Table 2).
Milk and fat yields were increased in cows treated with sodium salicylate, with the greatest differences observed in third or greater lactation cows. The divergence in milk yield observed in
6
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3P cows at the end of the third week of lactation was confirmed to affect the entire lactation.
Others who have administered aspirin to transition dairy cows reported increases in milk yield
around peak lactation compared with controls. Conversely, flunixin meglumine administered
for 3 days postpartum did not affect milk yield, suggesting that the type of NSAID administered is critical in determining milk production responses. Overall, SS administration during
the first week of lactation seems to increase production and potentially profit in ≥3rd lactation
cows, but it is not a beneficial management practice for primiparous cows, in which SS tended
to decrease milk production and increase cows’ risk of being removed from the herd.
It is important to note that SS is not approved for commercial use for the purposes as described
in this paper. In addition, although veterinary forms of aspirin are marketed with label indications for pain, fever, and inflammation in the U.S., the FDA has not formally approved this
drug; consequently, withdrawal times have not been established for food-producing animals.
These results should be viewed as establishing a critical role of inflammatory pathways during
early lactation, with effects that endure throughout the lactation. Future research may reveal
broadly applicable techniques to put this new knowledge to work.

Table 1. Estimated 305-day yields of milk, fat, and protein
P-value
Variable
Milk yield (× 1,000 lb)
Fat yield (lb)
Protein yield (lb)

Sodium
salicylate
27.3
1023.1
807.0

Control
26.0
901.8
774.0

SEM
6.6
24.3
19.9

Treatment
0.16
<0.01
0.23

Parity
<0.01
<0.01
<0.01

Treatment
× parity
<0.01
<0.01
0.08

Table 2. Reasons cows left herd1

Reason
Foot or leg
Low production
Reproduction
Injury
Death
Mastitis
Udder
Total

First
Control
....
....
1
....
....
....
....
1

2

SS
....
1
3
....
....
2
....
6

Parity
Second
Control
SS
....
....
1
....
1
2
....
....
1
1
2
2
1
....
6
5

Third or greater
Control
SS
1
....
....
....
1
1
....
1
1
....
1
....
....
....
4
2

Total
1
2
9
1
3
7
1
24

1

All values are numerical counts based on parity and treatment for each specific reason cows were removed from the herd.
SS: sodium salicylate treatment.

2
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Figure 1. A treatment × parity interaction (P < 0.01) was detected for milk yield with third-parity
sodium salicylate (SS) cows having greater milk yield and a tendency for first-parity SS cows to
have a lesser milk yield. No difference was detected for second-parity cows.
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Figure 2. A treatment × parity interaction (P < 0.01) was observed for 305-day milk fat yield,
reflecting greater milk fat yield in third-parity cows treated with sodium salicylate (SS).
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Figure 3. A tendency (P = 0.08) for a treatment × parity interaction was found for 305-day milk
protein yield, with third-parity sodium salicylate (SS)-treated cows tending to have a greater milk
protein yield through the lactation.
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